Academic Frontier
Biomaterials: PLGA nanoparticles are used for intracellular delivery of CRISPR complexes to enhance HbF expression in erythroid cells
QQ Academic Group: 1092348845
Detailed
In vitro gene editing of CD34 + hematopoietic stem cells and progenitor cells (HSPCs) provides a great opportunity to develop new therapies for a wide range of malignant and non-malignant diseases. Currently, delivering
- Previous： World record update! H
- Next： Nature Communications
